Search

You searched for "PDR"

710 results found

Issues with standard practice: Luer lock syringes in cataract surgery

4 December 2025 | | EYE - Cataract
For a few years, we have worked together with the practice variance surveys to tease out differences in the way we work and to discuss issues that arise. I hope that we have learnt some lessons and reflected on what...

What's trending Jun/Jul 2020

5 June 2020 | | EYE - Cornea, EYE - General
Here in the UK, we’ve been in lockdown since 23 March 2020, with much of the rest of the world entering degrees of lockdown since February-March 2020. COVID-19 has dominated the headlines and social media, so without further ado, I...

Semaglutide and vision loss: A new concern for NAION risk?

4 December 2025 | | EYE - Neuro-ophthalmology
This article has been verified for CPD. Click the button below to answer a few short questions and download a form to be included in your CPD folder. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as transformative agents in...

A closer look at the new wave of glaucoma surgery – radical or old school?

1 October 2016 | | EYE - Glaucoma
Glaucoma is a challenging condition to treat because the exact pathophysiology remains unclear and the only readily modifiable factor is the intraocular pressure (IOP). Additionally, most glaucoma patients are completely asymptomatic, yet are often subjected to lifelong medical therapy. The...

Well-presented scholarly research work will reduce chances of journal rebuttal

1 April 2018 | | EYE - General
Submitting to an academic journal? Are you aware of the requirements and constraints of relevant copyright laws? Rod McNeil provides a guide for aspiring authors. Getting published in peer-reviewed academic and medical journals is not easy. But careful attention to...

An eyeful of independence

1 August 2014 | | EYE - General
Scots will decide this September whether or not Scotland should be an independent sovereign state. “As all key areas of our business are already fully devolved, it’s very much business as usual for us,” noted a spokesperson for Healthcare Improvement...

Toxoplasmosis and the associated retinochoroiditis: important facts and when to treat

1 April 2017 | | EYE - Vitreo-Retinal
Annie SeeWah Tung provides an overview of toxoplasmosis retinochoroiditis, including guidance on which cases should be treated and the treatment options. Toxoplasmosis retinochoroiditis is an infectious condition that is characterised by retinochoroidal lesions commonly in the posterior pole and is...

Troubleshooting in LASIK

1 April 2017 | | EYE - Cataract, EYE - Refractive
Contemporary laser in situ keratomileusis (LASIK) is safe and effective. It remains the dominant intervention in routine refractive surgery for a good reason: predictable results, rapid visual recovery, and relatively simple strategies for revision treatment. Over 95% of patients are...

Diary from my elective: a Parisian experience

2 December 2019 | | EYE - General
The author explains how a research institute’s dedication to multidisciplinary collaboration helped him to discover a passion for academic ophthalmology. The elective aspect to the final year of a medical degree, through its change of scenery and immersion into another...

Code-Free Deep Learning: a step into the future of ophthalmology

3 October 2022 | | EYE - General
A new focus has arisen within the research domain of artificial intelligence (AI) in healthcare called code-free deep learning (CFDL), and recent research demonstrates that ophthalmology is becoming one of the leading specialties in this field. Artificial intelligence (AI) is...

The future of SLT?

2 February 2024 | | EYE - General, EYE - Glaucoma
For Feb/Mar 2024, we are looking at a recently released laser machine to perform direct SLT – selective laser trabeculoplasty (DSLT). Although SLT is well known, DSLT is sufficiently novel that a brief description is a good place to start....

The Spectacle Makers’ Charity takes up the challenge of glaucoma in Nigeria

16 August 2022
The Glaucoma-NET was established by the VISION 2020 LINKS Programme in 2021 to address the high levels of irreversible blindness due to glaucoma in low-income countries. It aims to preserve the sight of people with glaucoma through bringing together patients, clinicians, researchers, NGOs and Ministries of Health, with a lasting and sustainable impact.